Join
Live feed
·
INSIDERFilingvia Quantisnow
CAMP4 Therapeutics Corporation logo

Large owner Enavate Sciences Gp, Llc converted options into 2,422,166 shares and bought $14,999,996 worth of shares (1,363,636 units at $11.00) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CAMP (CAMP4 Therapeutics Corporation) and more on Quantisnow.